| Literature DB >> 34884384 |
Piotr Malara1,2, Susanne Bierbaum3,4, Beata Malara5.
Abstract
The objective of this review is to evaluate, on the basis of the available literature, if anterior open bite (AOB) can be successfully treated with the intrusion of molar teeth using skeletal anchorage in non-growing patients and adults and if this treatment modality provides comparable results to those obtained by orthognathic surgery procedures.Entities:
Keywords: anterior open bite; molar intrusion; orthognathic surgery; skeletal anchorage
Year: 2021 PMID: 34884384 PMCID: PMC8658589 DOI: 10.3390/jcm10235682
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Search terms used to extract suitable articles related to the topic of the review.
| Problem | Intervention Q1 | Intervention Q2 | Outcome |
|---|---|---|---|
| “anterior open bite” | “posterior teeth intrusion” | “orthognathic surgery” | “anterior open bite correction” |
| AOB | “molar intrusion” | LeFort I | “AOB correction” |
| Adult * | “absolute anchorage” | LeFort 1 | “positive overbite” |
| Non-growing | “skeletal anchorage” | “bilateral sagittal split osteotomy” | “mandibular autorotation” |
| Nongrowing | “temporary anchorage” | BSSO | |
| Adolescent * | TAD |
Q1—molar intrusion with skeletal anchorage; Q2—orthognathic surgery procedures including LIO with or without BSSO mandibular surgery; AOB—anterior open bite; TAD—temporary anchorage device; BSSO—bilateral sagittal split osteotomy; *—any group of characters, including no character.
Assessment of the risk of bias in the included articles by the methodological index for non-randomized trials tool (MINOR).
| Deguchi et al. 2011 | |
|---|---|
|
A clearly stated aim | 2 |
|
Inclusion of consecutive patients | 2 |
|
Prospective collection of data | 2 |
|
Endpoints appropriate to the aim of the study | 2 |
|
Unbiased assessment of the study end point | 0 |
|
Follow-up period appropriate | 2 |
|
Loss to follow-up less than 5% | 2 |
|
Prospective calculation of the study size | 0 |
|
An adequate control group | 2 |
|
Contemporary groups | 2 |
|
Baseline equivalence of groups | 1 |
|
Adequate statistical analysis | 2 |
| TOTAL: | 19 |
Assessment of the risk of bias in the included articles by the National Institute of Health (NIH) quality assessment tool for cohort studies.
| Scheffler et al. 2014 | Marzouk and Kassem 2016 | Teittinen et al. 2012 | Swinnen et al. 2001 | Fischer et al. 2000 | Proffit et al. 2000 | |
|---|---|---|---|---|---|---|
|
Was the research question or objective in this paper clearly stated? | 2 | 2 | 2 | 2 | 2 | 2 |
|
Was the study population clearly specified and defined? | 2 | 1 | 2 | 2 | 1 | 2 |
|
Was the participation rate of eligible persons at least 50%? | 0 | 0 | 0 | 0 | 0 | 0 |
|
Were all the subjects selected or recruited from the same or similar populations (including the same time period)? Were inclusion and exclusion criteria for being in the study prespecified and applied uniformly to all participants? | 1 | 1 | 2 | 1 | 1 | 1 |
|
Was a sample size justification, power description, or variance and effect estimates provided? | 0 | 1 | 0 | 1 | 0 | 0 |
|
For the analyses in this paper, were the exposure(s) of interest measured prior to the outcome(s) being measured? | 2 | 2 | 2 | 2 | 2 | 1 |
|
Was the timeframe sufficient so that one could reasonably expect to see an association between exposure and outcome if it existed? | 2 | 1 | 2 | 1 | 1 | 1 |
|
For exposures that can vary in amount or level, did the study examine different levels of the exposure as related to the outcome (e.g., categories of exposure, or exposure measured as continuous variable)? | 0 | 0 | 0 | 0 | 0 | 0 |
|
Were the exposure measures (independent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? | 2 | 1 | 2 | 2 | 2 | 2 |
|
Was the exposure(s) assessed more than once over time? | 2 | 2 | 2 | 2 | 2 | 0 |
|
Were the outcome measures (dependent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? | 2 | 1 | 2 | 2 | 2 | 2 |
|
Were the outcome assessors blinded to the exposure status of participants? | 0 | 0 | 0 | 0 | 0 | 0 |
|
Was loss to follow-up after baseline 20% or less? | 1 | 2 | 1 | 1 | 2 | 2 |
|
Were key potential confounding variables measured and adjusted statistically for their impact on the relationship between exposure(s) and outcome(s)? | 0 | 0 | 0 | 0 | 0 | 0 |
| TOTAL: | 16 | 14 | 17 | 16 | 15 | 13 |
Assessment of the risk of bias in the included articles by the Institute of Health Economics (IHE) Appraisal Tool.
| Baek et al. 2010 | Sugawara et al. 2002 | Ding et al. 2007 | |
|---|---|---|---|
|
Is the hypothesis/aim/objective of the study clearly stated? | 2 | 2 | 2 |
|
Are the characteristics of the participants included in the study described? | 2 | 1 | 1 |
|
Were the cases collected in more than one center? | 0 | 0 | 0 |
|
Are the eligibility criteria (i.e., inclusion and exclusion criteria) for entry into the study clearly stated? | 2 | 2 | 2 |
|
Were participants recruited consecutively? | 1 | 0 | 0 |
|
Did participants enter the study at a similar stage in the disease? | 1 | 1 | 1 |
|
Was the intervention of interest clearly described? | 2 | 2 | 2 |
|
Were additional interventions (co-interventions) reported in the study? | 0 | 0 | 0 |
|
Were the outcome measures established a priori? | 2 | 2 | 1 |
|
Were the relevant outcomes measured with appropriate objective and/or subjective methods? | 2 | 2 | 2 |
|
Were the relevant outcomes measured before and after the intervention? | 2 | 2 | 2 |
|
Were the statistical tests used to assess the relevant outcomes appropriate? | 2 | 2 | 2 |
|
Was the length of follow-up reported? | 2 | 2 | 2 |
|
Was the loss to follow-up reported? | 2 | 2 | 2 |
|
Does the study provide estimates of the random variability in the data analysis of relevant outcomes? | 0 | 0 | 0 |
|
Are the adverse events related to the intervention reported? | 1 | 0 | 1 |
|
Are the conclusions of the study supported by the results? | 2 | 2 | 2 |
|
Are both competing interests and sources of support for the study reported? | 2 | 2 | 2 |
| TOTAL: | 27 | 24 | 24 |
The strength of evidence for the evaluated outcomes.
| Number of Participants | Effect | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Studies | Study Design (s) | Risk of Bias | Inconsistency | Indirectness | Imprecision | Other Considerations | Intervention | Alternative Intervention | Relative | Absolute | Quality | Importance |
| The outcomes achieved by molar intrusion with skeletal anchorage | ||||||||||||
| The change in overbite on the incisors | ||||||||||||
| 5 | non-RCT, Coh, CS | moderate | not serious | not serious | not serious | no blinding | 77 | 15 | 3.2 | moderate | important | |
| The change in lower facial height | ||||||||||||
| 4 | non-RCT, Coh, CS | moderate | not serious | not serious | not serious | no blinding, low ss | 51 | 15 | moderate | important | ||
| Mandibular autorotation | ||||||||||||
| 5 | non-RCT, Coh, CS | moderate | not serious | not serious | not serious | no blinding | 77 | 15 | −2.2 | moderate | important | |
| The change in overbite on the incisors (1-year follow-up) | ||||||||||||
| 5 | non-RCT, Coh, CS | moderate | not serious | not serious | not serious | no blinding | 77 | 15 | moderate | important | ||
| The change in lower facial height (1-year follow-up) | ||||||||||||
| 4 | non-RCT, Coh, CS | moderate | not serious | not serious | not serious | no blinding, low ss | 18 | 15 | low | not | ||
| Mandibular distorotation (1-year follow-up) | ||||||||||||
| 4 | non-RCT, Coh, CS | moderate | not serious | not serious | not serious | no blinding, low ss | 44 | 15 | moderate | important | ||
| The outcomes achieved by orthognathic surgery procedures | ||||||||||||
| The change in overbite on the incisors | ||||||||||||
| 4 | Coh, CS | moderate | not serious | not serious | not serious | no blinding | 141 | 2.4 | moderate | important | ||
| Mandibular autorotation | ||||||||||||
| 4 | Coh, CS | moderate | not serious | not serious | not serious | no blinding | 141 | −4.8 | moderate | important | ||
| The change in overbite on the incisors (1-year follow-up) | ||||||||||||
| 2 | Coh | moderate | not serious | not serious | not serious | no blinding | 107 | moderate | important | |||
Non-RCT—non-randomized clinical trial, Coh—cohort studies, CS—case series, ss—sample size, CI—confidence interval.
Figure 1Flow diagram of the literature search.
Characteristics of studies included in the review.
| Study | Type of Intervention | Study Design | Number of Patients | Mean Age of Patients or Range (Years) | Mean Active Treatment Time (Months) | Analyzed Measurements for This Review | Maximum Follow-Up Time (Years) |
|---|---|---|---|---|---|---|---|
| Baek et al. 2010 | Molar intrusion with mini-implants and elastomeric chain and transpalatal bar | Prospective | 9 | 23.7 | 7.8 | Overbite | 3 |
| Scheffler et al. 2014 | Temporary anchorage devices in the zygomatic buttress area connected to the acrylic splint with NiTi coil springs | Retrospective | 33 | 24.1 | 6.6 | Overbite | 2 |
| Sugawara et al. 2002 | Zygomatic mini-plates | Retrospective | 9 | 21.1 | 14.9 | Overbite; MP-FH | 1 |
| Deguchi et al. 2011 | Miniscrews on the buccal side of molar area with power chain or ligature wire | Prospective, Non-randomized Clinical trial | 15 | 25.7 | 36 | Overbite | 2 |
| Marzouk and Kassem 2016 | Zygomatic titanium mini-plates fixed with 3 screws | Retrospective | 26 | 22.5 | 7.5 | Overbite | 3 |
| Ding et al. 2007 | Surgical-orthodontic, LefFort I and BSSO; fixation with plates and screws | Retrospective | 10 | 24.5 | NA | Overbite | 15 |
| Teittinen et al. 2012 | surgical-orthodontic, maxillary or bimaxillary | Retrospective | 24 | 29.3 (maxillary) | NA | Overbite | 3 |
| Swinnen et al. 2001 | surgical-orthodontic, maxillary or bimaxillary | Retrospective | 49 | 20.9 (women) | NA | Overbite | 1 |
| Fischer et al. 2000 | surgical-orthodontic, LefFort I and BSSO | Retrospective | 58 | 23 | NA | Overbite | 1 |
| Proffit et al. | surgical-orthodontic, maxillary or bimaxillary | Retrospective | 54 | 21.8 (maxillary) | NA | Overbite | 3 |
BSSO—bilateral sagittal split osteotomy; NiTi—nickel–titanium; NA—not applicable; SN-GoMe, U6-PP, SN-GoGn, MP-PP, FMA, U6-HRL, MP-FH, SN-MP, SN-PP, N-Me, ANS-Me—there are according explanations in Table 7.
Cephalometric measurements used in selected articles relevant to this review.
| Measurement | Type of Measurement | Definition of the Measurement |
|---|---|---|
| Overbite | Linear | Distance between the incisal edges of the upper central incisor (U1) and the lower central incisor (L1) perpendicular to the horizontal reference line (HRL) |
| SN-GoMe | Angular | Angle formed by the line going through cephalometric points sella (S)–nasion (N) and the line passing through the points gonion (Go)–menton (Me) |
| SN-GoGn | Angular | Angle formed by the line passing through cephalometric points sella (S)-nasion (N) and the line passing through the points gonion (Go)–gnathion (Gn) |
| MP-PP | Angular | Angle formed by the mandibular plane (MP) and the palatal plane (PP) |
| FMA | Angular | Angle formed by Frankfort horizontal plane and mandibular plane |
| SN-MP | Angular | Angle formed by the line going through cephalometric points sella (S)–nasion (N) and mandibular plane |
| SN-PP | Angular | Angle formed by the line going through cephalometric points sella (S)–nasion (N) and palatal plane |
| MP-FH | Angular | Angle formed by mandibular plane (MP) and Frankfort horizontal plane (FH); synonym of FMA |
| N-Me | Linear | Distance between nasion (N) and menton (Me) |
| ANS-Me | Linear | Distance between anterior nasal spine (ANS) and menton (Me) |
| U6-PP | Liner | Perpendicular distance between mesiobuccal cusp of the upper first molar and palatal plane (PP) |
| U6-HRL | Linear | Perpendicular distance between mesiobuccal cusp of the upper first molar and horizontal reference line (HRL) |
| Anterior face height (AFH) | Linear | Distance between nasion (N) and menton (Me) |
| Lower face height (LFH) | Linear | Distance between anterior nasal spine (ANS) and menton (Me) |
The change in overbite measured on the incisors as a result of anterior open bite treatment by molar intrusion using skeletal anchorage (mm).
| Study | Pre-Treatment | Post-Treatment | Change in |
|---|---|---|---|
| Baek et al. 2010 | −3.91 (1.65) | 1.65 (0.82) | 5.56 (1.94) * |
| Scheffler et al. 2014 | −1.2 (1.7) | 1.0 (NR) | 2.2 (1.6) SNR |
| Sugawara et al. 2002 | −2.8 (1.8) | 2.1 (0.8) | 4.9 (NR) SNR |
| Deguchi et al. 2011 | −4.4 (1.2) | 1.8 (1.1) | 6.2 (1.7) * |
| Marzouk and Kassem 2016 | −4.7 (2.3) | 2.18 (0.48) | 6.93 (1.99) ** |
NR—not reported; SD—standard deviation; * significant difference compared with pre-treatment (p < 0.05); ** significant difference compared with pre-treatment (p < 0.01); SNR—significance not reported.
Figure 2Change in the values of the distance of the mesial buccal cusp of the first upper molar from the palatal plane (mm); NR—not reported.
The change in anterior facial height or lower facial height as a result of anterior open bite treatment by molar intrusion using skeletal anchorage (mm).
| Study | Measurement | Pre-Treatment | Post-Treatment | Change in |
|---|---|---|---|---|
| Baek et al. 2010 | AFH | 133.95 (5.55) | 131.41 (6.10) | −2.53 (1.90) |
| Scheffler et al. 2014 | LFH | NR | NR | −1.6 (2.2) |
| Sugawara et al. 2002 | LFH | 76.1 (5.8) | 74.6 (6.0) | −1.5 (NR) |
| Deguchi et al. 2011 | LFH | 74.7 (5.9) | 72.2 (5.1) | −2.6 (2.5) |
| Marzouk and Kassem 2016 | NR | NR | NR | NR |
NR—not reported; SD—standard deviation; AFH—anterior facial height; LFH—lower face height.
The change in overbite measured on the incisors as a result of orthognathic surgery (mm).
| Study | Pre-Treatment | Pre-Surgery | Post-Surgery | Change in |
|---|---|---|---|---|
| Ding et al. 2007 | −3.2 (NR) | −3.2 (NR) | 0.6 (NR) | 3.8 (NR) |
| Teittinen et al. 2021 | NR | −2.55 (1.41) M | 1.23 (1.05) M | 3.78 (NR) M |
| Swinnen et al. 2001 | −0.7 MI | −0.6 MI | 1.3 MI | 1.9 MI |
| Fischer et al. 2000 | NR | −0.9 (2.6) | 1.3 (1.1) | 2.2 (2.4) |
| Proffit et al. 2000 | NR | NR | NR | NR |
NR—not reported; SD—standard deviation; M—maxillary group; B—bimaxillary group; MI—maxillary intrusion; ME—maxillary extrusion.
The change in the facial height as a result of orthognathic surgery (mm).
| Study | Measurement | Pre-Treatment | Pre-Surgery | Post-Surgery | Change |
|---|---|---|---|---|---|
| Swinnen et al. 2001 | N-Me | 139.1 MI | 139.7 MI | 134.2 MI | −5.5 MI |
| ANS-Me | 139.1 MI | 139.7 MI | 134.2 MI | −5.5 MI |
MI—maxillary intrusion; ME—maxillary extrusion; N-Me—distance from nasion (N) to menton (Me); ANS-Me—distance from anterior nasal spine (ANS) to menton (Me).
The results of measurements indicating mandibular autorotation as a result of anterior open bite treatment by molar intrusion using skeletal anchorage (degrees).
| Study | Measurement | Pre-Treatment | Post-Treatment | Change |
|---|---|---|---|---|
| Baek et al. 2010 | SN-GoMe | 45.44 (4.11) | 43.41 (4.41) | −2.03 (1.59) |
| Scheffler et al. 2014 | SN-GoGn | NR | NR | −1.2 (1.0) |
| Sugawara et al. 2002 | MP-FH | 33.1 (2.1) | 31.7 (2.4) | −1.3 (NR) |
| Deguchi et al. 2011 | MP-SN | 45.8 (6.0) | 42.2 (6.7) | −3.6 (2.1) |
| Marzouk and Kassem 2016 | MP-SN | 49.1 (3.1) | 46.9 (3.9) | −2.13 (0.21) |
NR—not reported; SN-GoMe—angle formed by sella–nasion (SN) line and gonion–menton (Go-Me) line; SN-GoGn—angle formed by sella–nasion (SN) line and gonion–gnathion (Go-Gn) line; MP-FH—angle formed by mandibular plane and Frankfort horizontal plane; MP-SN—angle formed by mandibular plane and sella–nasion (SN) line.
Mean change in measurements indicating mandibular autorotation as a result of orthognathic surgery (degrees).
| Study | Measurement | Pre-Treatment | Pre-Surgery | Post-Surgery | Change |
|---|---|---|---|---|---|
| Ding et al. 2007 | PP-SN | 11.0 (NR) | 11.0 (NR) | 15.8 (NR) | 4.8 (NR) |
| MP-SN | 42.0 (NR) | 42.5 (NR) | 41.2 (NR) | −1.3 (NR) | |
| MP-PP | 31.1 (NR) | 31.1 (NR) | 25.0 (NR) | −6.1 (NR) | |
| Teittinen et al. 2021 | PP-SN | NR | 5.15 (2.16) M | 9.59 (3.23) M | 4.44 (NR) M |
| 5.49 (3.91) B | 8.27 (3.91) B | 2.78 (NR) B | |||
| MP-SN | NR | 38.15 (6.33) M | 34.17 (7.30) M | −3.95 (NR) M | |
| 42.08 (9.27) B | 37.48 (8.47) B | −4.6 (NR) B | |||
| MP-PP | NR | 32.98 (6.57) M | 26.17 (5.78) M | −6.81 (NR) M | |
| 36.57 (9.40) B | 29.24 (7.10) B | −7.33 (NR) B | |||
| Swinnen et al. 2001 | PP-SN | 7.9 (NR) MI | 7.8 (NR) MI | 9.2 (NR) MI | 1.4 (NR) MI |
| 8.9 (NR) ME | 9.4 (NR) ME | 11.8 (NR) ME | 2.4 (NR) ME | ||
| Fischer et al. 2000 | MP-SN | 46.2 (6.8) | 42.2 (6.7) | −4.0 (3.1) | |
| MP-PP | 39.6 (6.0) | 35.0 (6.6) | −4.6 (4.6) | ||
| Proffit et al. 2000 | NR | NR | NR | NR | NR |
NR—not reported; M—maxillary group; B—bimaxillary group; MI—maxillary intrusion; ME—maxillary extrusion; MP-SN—angle formed by mandibular plane and sella–nasion (SN) line; MP-PP—angle formed by mandibular plane and palatal plane; PP-SN—angle formed by palatal plane and sella–nasion (SN) line.
Changes in selected values characterizing stability of results of AOB treatment by molar intrusion using skeletal anchorage.
| Study | Measurement | Pre-Treatment Mean (SD) | 1-Year | Change | 2-Year | Change | 3-Year Follow-Up | Change |
|---|---|---|---|---|---|---|---|---|
| Baek et al. 2010 | Overbite | 1.65 (0.82) | 0.66 | −0.99 * | NR | NR | 0.45 | −0.44 * |
| AFH | 131.41 (6.10) | 131.86 (5.54) | 0.45 * | NR | NR | 132.32 (5.87) | 0.91 * | |
| SN-GoMe | 43.41 (4.41) | 43.68 (4.88) | 0.29 * | NR | NR | 43.98 (4.76) | 0.57 * | |
| U6-PP | 24.50 (1.64) | 24.89 (1.69) | 0.39 * | NR | NR | 24.94 (1.68) | 0.44 * | |
| Scheffler et al. 2014 | Overbite | 1.0 | 0.7 | −0.3 * | 0.3 (NR) | −0.7 * | NR | NR |
| LFH | NR | NR | 0.2 | NR | 0.3 | NR | NR | |
| SN-GoGn | NR | NR | 0.0 | NR | 0.0 | NR | NR | |
| U6-PP | NR | NR | 0.5 | NR | 1.0 * | NR | NR | |
| Sugawara et al. 2002 | Overbite | 2.1 | 1.2 | −0.9 * | NR | NR | NR | NR |
| LFH | 74.6 | 75.2 | 0.6 * | NR | NR | NR | NR | |
| MP-FH | 31.7 | 32.2 | 0.5 * | NR | NR | NR | NR | |
| U6-PP | 25.0 | 25.1 | 0.1 * | NR | NR | NR | NR | |
| Deguchi et al. 2011 | Overbite | 1.8 | 1.0 | −0.8 | NR | NR | NR | NR |
| LFH | 72.2 | 72.2 | 0.0 * | NR | NR | NR | NR | |
| MP-SN | 42.2 | 43.8 | 1.6 * | NR | NR | NR | NR | |
| U6-PP | 24.6 | 25.1 | 0.5 * | NR | NR | NR | NR | |
| Marzouk and Kassem 2016 | Overbite | 2.18 (0.48) | 1.61 | −0.57 * | NR | NR | 1.41 | −0.2 * |
| MP-SN | 46.9 (3.9) | 47.2 | 0.3 * | NR | NR | 47.4 | 0.2 * | |
| U6-PP | 25.23 (2.14) | 25.54 (2.17) | 0.31 | NR | NR | 25.64 (2.17) | 0.10 * |
*—calculated value; NR—not reported; SD—standard deviation; AFH—anterior face height; LFH—lower face height; SN-GoMe—angle formed by sella–nasion (SN) line and gonion–menton (Go-Me) line; SN-GoGn—angle formed by sella–nasion (SN) line and gonion–gnathion (Go-Gn) line; FMA—angle formed by Frankfort horizontal line and mandibular plane; MP-FH—angle formed by mandibular plane and Frankfort horizontal plane; MP-SN—angle formed by mandibular plane and sella–nasion (SN) line.
Changes in selected values characterizing stability of results of AOB treatment by orthognathic surgery procedures.
| Study | Observation Time (Years) | Measurement | Post-Surgery | Follow-Up | Change |
|---|---|---|---|---|---|
| Ding et al. 2007 | 15 | Overbite | 0.6 (NR) | 1.5 (NR) | 0.9 (NR) |
| PP-SN | 15.8 (NR) | 13 (NR) | −2.6 (NR) | ||
| MP-SN | 41.2 (NR) | 42.1 (NR) | 0.9 (NR) | ||
| MP-PP | 25.0 (NR) | 28 (NR) | 2.9 (NR) | ||
| Teittinen et al. 2021 | 3.5 | Overbite | 1.23 (1.05) M | 1.85 (0.93) M | 0.62 * M |
| 0.98 (1.53) B | 0.73 (0.93) B | −0.25 B | |||
| PP-SN | 9.59 (3.23) M | 7.45 (3.08) M | −2.14 M | ||
| 8.27 (3.91) B | 7.06 (4.14) B | −1.21 B | |||
| MP-SN | 34.17 (7.30) M | 35.84 (5.95) M | 1.67 M | ||
| 37.48 (8.47) B | 41.25 (10.37) M | 3.77 B | |||
| MP-PP | 26.17 (5.78) M | 28.38 (5.80) B | 2.21 M | ||
| 29.24 (7.10) B | 34.20 (8.78) M | 4.96 B | |||
| Swinnen et al. 2001 | 1 | Overbite | 1.3 (NR) MI | 1.8 (NR) MI | 0.5 * MI |
| 0.2 (NR) ME | 0.8 (NR) ME | 0.6 * ME | |||
| PP-NS | 9.2 (NR) MI | 8.0 (NR) MI | −1.2 * MI | ||
| 11.8 (NR) ME | 9.3 (NR) ME | −2.5 * ME | |||
| N-Me | 134.2 (NR) MI | 133.6 (NR) MI | −0.6 * MI | ||
| 136.3 (NR) ME | 134.2 (NR) ME | −2.1 * ME | |||
| ANS-Me | 81.3 (NR) MI | 81.7 (NR) MI | 0.4 * MI | ||
| 76.3 (NR) ME | 75.4 (NR) ME | −0.9 * ME | |||
| Fischer et al. 2000 | 1 | Overbite | 1.3 (2.6) | 0.8 (1.4) | −0.5 (1.3) |
| MP-SN | 42.2 (6.7) | 43.7 (6.7) | 1.4 (2.0) | ||
| MP-PP | 35.0 (6.6) | 36.7 (6.3) | 1.7 (2.8) | ||
| Proffit et al. 2000 | 3 | Overbite | NR | NR | 0.02 (1.21) M |
| NR | NR | −0.25 (1.25) B |
*—calculated value; NR—not reported; SD—standard deviation; MP-SN—angle formed by mandibular plane (MP) and sella–nasion (SN) line; PP-SN—angle formed by palatal plane (PP) and sella–nasion (SN) line; MP-PP—angle formed by mandibular plane (MP) and palatal plane (PP); N-Me—distance between nasion (N) and menton (Me); ANS-Me—distance between anterior nasal spine (ANS) and menton (Me), overbite, N-Me, ANS-Me expressed in mm; PP-SN, MP-SN, MP-PP expressed in degrees.